,i #aah? ,,congress #a/ ,session ,h4 ,r4 #fbhh ,,9 ,,! ,,h\se ,,( ,,repres5tatives ,novemb] #h1 #bjbc,mr4 ,b]a 7= himself & ,mr4 ,kelly ( ,p5nsylvania7 introduc$ ! foll[+ bill2 :i* 0 ref]r$ to ! ,committee on ,en]gy & ,comm]ce ,a ,,bill ,to am5d ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act to provide = a ,p$iatric ,bra9 ,tumor ,real-,_w ,data ,regi/ry ,program1 & = o!r purposes4 #a4 ,%ort title ,?is ,act may be cit$ z ! ,data = ,p$iatric ,bra9 ,canc] ,act ( #bjbc4 #b4 ,f9d+s ,congress f9ds ! foll[+3 7#a7 ,r&omiz$ cl9ical trials require ! use ( control gr\ps to s]ve z ! basel9e = det]m9+ ! effectiv5ess ( a /udy treatm5t4 7#b7 ,because ( ! r>ity ( "s diseases1 x is (t5 h>d to f9d en\gh /udy p>ticipants 9 a suffici5t am\nt ( "t1 mak+ r&omiz$ cl9ical trials = ^! treatm5ts infeasible4 ,c\ple ?is ) ! fact t ! curr5t /&>d ( c>e = _m r>e diseases is ineffective 7(t5 lead+ to dea?71 mak+ adm9i/]+ ! curr5t /&>d ( c>e une?ical4 7#c7 ,9 ^! cases1 data reflect+ pati5t treatm5t 9 r\t9e cl9ical practice c be us$ to develop ext]nal control gr\ps = s+learm trials4 ,cl9ical trials us+ ext]nal control cohorts c provide valuable b5*m>k results on pot5tial comp>ator treatm5t efficacy4 7#d7 ,! ,food & ,drug ,adm9i/ration 79 ?is section ref]r$ to z ! ,,fda7 has di/ribut$ draft guidance on ?is issue comm5t+ on consid]ations = ! use ( real-_w data = ! design & conduct ( ext]nally controll$ trials4 7#e7 ,?r\gh collaboration ) community advocates & indu/ry p>tn]s ) input f ! ,,fda1 rese>*]s focus$ on atypical t]atoid rhabdoid tumor 79 ?is section ref]r$ to z ,,atrt71 an ultra-r>e & poor prognosis p$iatric bra9 tumor1 h tak5 ! lead 9 ! design ( real-_w data sets4 7#f7 ,because ( ! advancem5ts 9 ! rese>*1 ,,atrt has pres5t$ itself z ! ideal c&idate to pilot ! developm5t ( real-_w data sets = use 9 ext]nal control cohorts4 #c4 ,p$iatric ,bra9 ,tumor ,real-,_w ,data ,regi/ry ,program ,*apt] ,x ( ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act 7#ba ,u4,s4,c4 #cia et seq47 is am5d$ by add+ at ! end ! foll[+3 #ajae4 ,p$iatric ,bra9 ,tumor ,real-,_w ,data ,regi/ry ,program 7a7 ,9 g5]al ,! ,secret>y %all c>ry out a program1 to be kn[n z ! ,p$iatric ,bra9 ,tumor ,real-,_w ,data ,regi/ry ,program1 to /r5g!n & exp& activities relat$ to ! collection1 %>+1 & use ( real-_w data = *ildr5 ) bra9 tumors4 7b7 ,requirem5ts ,9 c>ry+ out ! program "u ?is section1 ! ,secret>y %all-- 7#a7 develop & ma9ta9 7or support ! developm5t & ma9t5ance (7 a regi/ry ( real-_w data = *ildr5 ) atypical t]atoid rhabdoid tumors2 7#b7 consid] new & innovative approa*es & te*nology = data collection1 integration1 & analysis2 7#c7 cont9ue & exp& activities1 :i* may include exi/+ data collection activities1 to e/abli% real-_w database infra/ructure2 7#d7 provide support = data integration1 bio9=matics1 & /ati/ical analyses2 & 7#e7 id5tify pot5tial uses ( real-_w data regi/ries z ext]nal control cohorts = p$iatric bra9 tumor cl9ical trial design4 7c7 ,collaboration & consultation ,9 c>ry+ out ! program "u ?is section1 ! ,secret>y %all collaborate & consult1 z appropriate1 ) public & private entities1 includ+ relevant dep>tm5ts & ag5cies1 academic in/itutions1 & indu/ry4 7d7 ,grants1 contracts1 & coop]ative agreem5ts 7#a7 ,aw>ds ,9 c>ry+ out ! program "u ?is section1 ! ,secret>y %all aw>d grants1 contracts1 & coop]ative agreem5ts to academic in/itutions & o!r entities ) relevant exp]tise 9 p$iatric neuro-oncology or ! collection1 integration1 & analysis ( real-^w data4 7#b7 ,application 7,a7 ,9 g5]al ,to seek an aw>d "u p>agraph 7#a71 an entity describ$ 9 su* p>agraph %all submit to ! ,secret>y an application at su* "t1 9 su* mann]1 & conta9+ su* in=mation z ! ,secret>y may require4 7,b7 ,cont5ts ,an application "u subp>agraph 7,a7 %all include a description ( h[ ! applicant w p>tn]1 z applicable1 ) academic in/itutions or a consortium ( academic in/itutions t h relevant exp]tise1 su* z exp]tise 9 p$iatric neuro-oncology1 cl9ical rese>*1 or ! application ( bio9=matics or /ati/ics4 7e7 ,au?orization ( appropriations ,= c>ry+ out ?is section1 !re are au?oriz$ to be appropriat$ #b1jjj1jjj = fiscal ye> #bjbe4 4